Viewing Study NCT02721433


Ignite Creation Date: 2025-12-25 @ 2:45 AM
Ignite Modification Date: 2026-03-02 @ 4:23 PM
Study NCT ID: NCT02721433
Status: COMPLETED
Last Update Posted: 2020-12-02
First Post: 2016-03-10
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: 4-weekly Versus 12-weekly Administration of Bone-targeted Agents in Patients With Bone Metastases
Sponsor: Ottawa Hospital Research Institute
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Breast Cancer View
None Prostate Cancer View
None Metastasis View
Keywords: